International Cannabis Weekly: 65

• Canadian cannabis companies seek European investment ahead of October 17.
• Cannabis executives predict a European market boom in the next three years.
• Organigram invests €4.4 million in European hemp and CBD producer Eviana.
• Invictus seeks EU-GMP Certification after raising €17.4 million in funding.
• GW Pharma plans to sell €260 million of American depositary shares.
• Cannabis beverages could be a €521 million market in the US by 2022.
• Queensland opens its first medical cannabis clinic.
• AusCann’s Chilean subsidiary signsan MoU with Khiron Life Sciences.
• Canadian cannabis companies are using Latin America as global export centre.

• France’s ANSM announces members of the special committee on medical cannabis.
• European Parliament’s committee approves initial motion on medical cannabis.
• An update on Denmark’s new medical cannabis pilot programmes.
• Civil society groups push Thai government to legalise medical cannabis.
• Guam Senate debates a bill allowing patients to cultivate medical cannabis.
• US FDA recommends that CBD be descheduled.

• Study finds evidence that THC can reduce toxic proteins associated with Alzheimer’s.
• A start-up is growing cannabis on the International Space Station.
• Columbia Care sign deal to develop anti-snoring cannabis product.
• Naples start-up begins selling CBD for pets.

Prohibition Partners is pleased to announce the release of The LATAM Cannabis Report™. The report explores the medical, recreational, and industrial cannabis industries across the $12.7 billion market. The report is the most comprehensive review of the industry to date, identifying the regulatory guidelines and analysing market data across 11 LATAM states